Warfarin Dosing Calculator - ACCP/ASH-Style Dose Adjustment

The warfarin dosing calculator turns a current INR, the target INR range, the current weekly warfarin dose, and the bleeding status into a labeled weekly and daily mg schedule with an ACCP/ASH-style percent change and a recheck interval. Each row maps an actual INR to a recommendation the clinic team and the patient can read together.

• • Stable clinic draw: A patient on warfarin for atrial fibrillation gets a labeled band tied to the current INR.
• • Subtherapeutic INR: An INR of 1.5 in a 2.0-3.0 target triggers a 5-20% maintenance dose increase and a possible booster.
• • Supratherapeutic INR: An INR of 4.0 on 35 mg/week with no bleeding returns a 15% reduction and a 1-day recheck.
• • Mechanical mitral valve target: A 2.5-3.5 target rebands the lookup to the higher-intensity recommendations.

Warfarin is a vitamin K antagonist that blocks hepatic synthesis of factors II, VII, IX, and X. The INR is the standardized readout the lab reports on the same plasma, and it is the single number the anticoagulation team titrates against. The INR Calculator gives the math behind the seconds, ISI, and reagent lot that go into that number.

The calculator reads five inputs, matches the actual INR to a labeled row in an ACCP/ASH-aligned chart, and applies the row's percent change to the current weekly dose. The chart switches automatically when the target range is set to 2.5-3.5 for mechanical mitral valves and recurrent VTE.

• Current INR: Most recent lab INR, between 0.5 and 10.
• Current weekly dose (mg): Total warfarin in a full week across all dose days.
• Target INR range: 2.0-3.0 for most indications, or 2.5-3.5 for mechanical mitral valves and recurrent VTE.
• Warfarin days per week: 7 for daily dosing, fewer for skip-day schedules.
• Bleeding status: Serious or life-threatening bleeding forces urgent reversal regardless of the calculated change.

The percent change is anchored to an INR range, a percent band (5%, 10%, 15%, or 20%), and a recheck interval. The new weekly mg and the per-day mg are the two numbers the patient takes home.

According to ACCP Holbrook 2012 (Chest supplement), the recommended therapeutic INR range for most vitamin K antagonist indications is 2.0 to 3.0 (Grade 1B), and the higher 2.5 to 3.5 range is reserved for mechanical mitral valves and some recurrent thromboembolism cases.

Renal function changes how long warfarin and bridging heparin stick around, and the GFR Calculator supports the parallel kidney review that often runs in anticoagulation clinics.

Four ideas carry most of the meaning of the percent change and the recheck interval.

Bleeding status overrides the row. A supratherapeutic INR with no bleeding follows the row; the same INR with serious bleeding is an urgent reversal pathway.

When a high INR comes with major bleeding and the team is moving toward reversal, the Fresh Frozen Plasma Dose Calculator supports the parallel volume and factor review that often runs alongside four-factor PCC.

Run the four numeric inputs and one clinical flag through the calculator, then read the labeled band the same way the clinic team would.

1. 1 Enter the current INR: Type the most recent value from the lab report, to one decimal place.
2. 2 Enter the current weekly dose: Add up every warfarin dose in a full week, in mg.
3. 3 Pick the target INR range: Use 2.0 and 3.0 for most indications, or 2.5 and 3.5 for mechanical mitral valves and recurrent VTE.
4. 4 Set the warfarin days per week: 7 for daily, fewer for skip-day schedules, so the per-day mg is right.
5. 5 Read the band and the recheck interval: Apply the recommendation label, new weekly mg, per-day mg, and recheck days.

A 65-year-old on warfarin for atrial fibrillation comes in with a draw of 4.0 on 35 mg/week in a 2.0-3.0 target. The calculator returns a 15% reduction, 29.8 mg/week, 4.26 mg/day, and a 1-day recheck.

When a low INR raises the question of a breakthrough clot and the team wants a bedside HIT pretest probability, the 4TS Score gives the parallel review that often runs in the same anticoagulation workup.

The math is short, but a labeled calculator makes the dose change auditable, repeatable, and easy to share with the patient.

• • ACCP/ASH-aligned row labels: Each actual INR maps to a labeled recommendation that mirrors the Holbrook 2012 and ASH 2018 charts.
• • Weekly and per-day mg in one place: The calculator returns the new total weekly mg and the per-day mg that splits that weekly total into the patient's actual schedule.
• • Built-in recheck interval: Each row carries a recheck interval in days, which is what the clinic and the patient both need to plan the next draw.
• • Bleeding-aware logic: Serious or life-threatening bleeding is handled as an urgent reversal pathway that does not depend on the calculated percent change.
• • Target-range aware: Switching from a 2.0-3.0 to a 2.5-3.5 target rebands the rows to the mechanical mitral valve recommendations without a second chart.

The result is most useful when paired with the same clinical reasoning the bedside team would use without the calculator. It does not measure a clotting factor, prescribe a dose, or replace a confirmatory INR draw.

When a low INR raises the question of a breakthrough clot and the team is working up a possible VTE, the Age-Adjusted D-Dimer Calculator supports the parallel rule-out workup that often sits next to a warfarin review.

The percent change and the recheck interval come from the INR, target range, dose, and bleeding status, but the dose that gets the patient to the next draw also depends on what is happening around the value.

• • The percent change is a guideline-anchored band, not a precision dose. Two patients with the same INR and target range can need different percent changes because of body weight, genotype, diet, and adherence.
• • The calculator does not handle the loading dose phase. Warfarin initiation is its own nomogram, and the percent change table is for the maintenance phase.
• • Bleeding overrides the row logic, but the calculator does not see bleeding severity on a continuous scale.

Bleeding risk, kidney function, pregnancy status, and the overall anticoagulation plan matter for what to do with the dose change, but those are not part of the percent change. They are the context the clinical team layers on top of the band.

Per the Omni Calculator warfarin dosing page, the weekly adjusted dose equals the current weekly dose multiplied by an adjustment factor that depends on the actual INR versus the target range.

Per the ASH 2018 VTE management guidelines, vitamin K antagonist therapy for VTE should be dosed to a target INR of 2.0 to 3.0, and dose adjustment should follow a structured protocol that uses the current INR and the patient's bleeding status.

When an elevated INR comes with metabolic acidosis or sepsis and the team is deciding on reversal, the Anion Gap Calculator supports the acid-base and electrolyte review that often needs to be done before any vitamin K is given.